...
首页> 外文期刊>Carcinogenesis >MicroRNA-365, down-regulated in colon cancer, inhibits cell Cycle progression and promotes apoptosis of colon cancer cells by probably targeting Cyclin D1 and Bcl-2
【24h】

MicroRNA-365, down-regulated in colon cancer, inhibits cell Cycle progression and promotes apoptosis of colon cancer cells by probably targeting Cyclin D1 and Bcl-2

机译:在结肠癌中下调的MicroRNA-365,可能通过靶向Cyclin D1和Bcl-2来抑制细胞周期进程并促进结肠癌细胞的凋亡

获取原文
获取原文并翻译 | 示例
           

摘要

Deregulated microRNAs participate in carcinogenesis and cancer progression, but their roles in cancer development remain unclear. In this study, miR-365 expression was found to be downregulated in human colon cancer tissues as compared with that in matched non-neoplastic mucosa tissues, and its downregulation was correlated with cancer progression and poor survival in colon cancer patients. Functional studies revealed that restoration of miR-365 expression inhibited cell cycle progression, promoted 5-fluorouracil-induced apoptosis and repressed tumorigenicity in colon cancer cell lines. Furthermore, bioinformatic prediction and experimental validation were used to identify miR-365 target genes and indicated that the antitumor effects of miR-365 were probably mediated by its targeting and repression of Cyclin D1 and Bcl-2 expression, thus inhibiting cell cycle progression and promoting apoptosis. These results suggest that downregulation of miR-365 in colon cancer may have potential applications in prognosis prediction and gene therapy in colon cancer patients.
机译:失调的microRNA参与癌变和癌症进展,但是它们在癌症发展中的作用仍不清楚。在这项研究中,发现miR-365在人结肠癌组织中的表达与匹配的非肿瘤黏膜组织相比被下调,并且其下调与结肠癌患者的癌症进展和不良的生存率相关。功能研究表明,恢复miR-365表达可抑制细胞周期进程,促进5-氟尿嘧啶诱导的细胞凋亡并抑制结肠癌细胞系的致瘤性。此外,使用生物信息学预测和实验验证来鉴定miR-365靶基因,并表明miR-365的抗肿瘤作用可能是由其靶向和抑制Cyclin D1和Bcl-2表达所介导的,从而抑制细胞周期进程并促进细胞凋亡。这些结果表明miR-365在结肠癌中的下调可能在结肠癌患者的预后预测和基因治疗中具有潜在的应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号